- 44% of Homeowners With a Mortgage Can't Sell: Zillow
- Tim Cook Should Tell Congress to Kiss His Ass
- Millennials Won't Be Debt Free Until They Die
- Biotech Stock Mailbag: Amarin, MannKind, Palatin
- What You Wear to the Office Still Matters
Article
Celsion: Run-Up Trade Into Thermodox Results
Traders are already bidding up shares of Celsion in anticipation of pivotal trial results.
07:01AM 11/14/12
Article
Short Trade: Supernus IPO Lock-Up
Supernus share should fall now that 10 million shares under lock-up can now be sold.
07:00AM 10/31/12
Article
How to Prep for the Inevitable Bursting of the Biotech Stock Bubble
Traders need to be less cocky and more prepared for when stocks fall.
07:00AM 10/17/12
Article
AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades
The biotech bull market has created a new category of swing trade catalysts.
07:05AM 10/09/12
Article
How to Trade Hemispherx Even If You Hate the Stock
Biotech swing trader Mark Messier warns to look at Hemispherx as a short-term trade, not an investment.
10:48AM 10/02/12
Article
Zogenix: Three Shots At Run-Up Trade
Get in Zogenix early before other traders start speculating over its chronic pain drug Zohydro.
08:00AM 09/26/12
Article
Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results
Biotech trader Mark Messier explains how to position trades ahead of two important biotech clinical trials.
07:31AM 09/19/12
Article
Dynavax: The BioRunUp Trade Into An FDA Panel
Biotech trader Mark Messier explains how to swing trade Dynavax into a Nov. 14 FDA advisory panel.
11:34AM 09/11/12